Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;217(2):299-306.
doi: 10.1002/path.2478.

Prostate cancer stem cells

S H Lang  1 , F M Frame, A T Collins
Affiliations
Review

Prostate cancer stem cells

S H Lang et al. J Pathol. 2009 Jan.

Abstract

Despite the discovery over 60 years ago by Huggins and Hodges that prostate cancers respond to androgen deprivation therapy, hormone-refractory prostate cancer remains a major clinical challenge. There is now mounting evidence that solid tumours originate from undifferentiated stem cell-like cells coexisting within a heterogeneous tumour mass that drive tumour formation, maintain tumour homeostasis and initiate metastases. This review focuses upon current evidence for prostate cancer stem cells, addressing the identification and properties of both normal and transformed prostate stem cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A frozen section of prostate labelled with α2-integrin antibody, directly labelled with fluorescein isothiocyanate (FITC) and viewed by confocal microscopy. Reproduced with permission from
Figure 2
Figure 2
A colony derived from a single PKH26-labelled prostate epithelial cell at day 4. As the cells divide, the intensity of fluorescence is diluted. Note the quiescent, bright cells at the edge of the colony
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Huggins C, Stevens RE, Jr, Hodges CV. Studies on prostate cancer: the effects of castration on advanced carcinoma of the prostate gland. Arch Surg. 1941;43:209–223.
    1. Edwards J, Krishna NS, Grigor KM, Bardett JM. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer. 2003;89:552–556. - PMC - PubMed
    1. Taplin ME, Rajeshkimar B, Halabi S, Werner CP, Woda BA, Picus J, et al. Androgen receptor mutations in androgen-independent prostate cancer. Cancer and Leukemia group B study, 9663. J Clin Oncol. 2003;21:2673–2678. - PubMed
    1. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to anti androgen therapy. Nat Med. 2004;10:33–39. - PubMed
    1. Li P, Yu X, Ge K, Melamed J, Roeder RG, Wang Z. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol. 2002;161:1467–1474. - PMC - PubMed

Publication types